Encore: Episode 7 November - 9th Annual 2021 C. diff. Conference
Update: 2022-08-30
Description
“Introducing a New Disinfection Technology Against C. diff.”
Jordan Bastian (Speaker) Infection Preventionist, CloroxPro Clinical and Scientific Affairs, Clorox Company
Ibezapolstat Update: Can Emerging Microbiome Findings Contribute to CDI Anti-Recurrence Effect?
Kevin Garey (Speaker) Chair of the Department of Pharmacy Practice and Translational Research and Professor of Pharmacy Practice, University of Houston College of Pharmacy
More Than a CDI: The Revolving Door and a Ray Of Hope.
Kathy Bischoff (Speaker) Coordinator, VHA Program, C Diff Foundation
Sponsored by
ACURX Pharmaceuticals
Clorox Healthcare
Jordan Bastian (Speaker) Infection Preventionist, CloroxPro Clinical and Scientific Affairs, Clorox Company
Ibezapolstat Update: Can Emerging Microbiome Findings Contribute to CDI Anti-Recurrence Effect?
Kevin Garey (Speaker) Chair of the Department of Pharmacy Practice and Translational Research and Professor of Pharmacy Practice, University of Houston College of Pharmacy
More Than a CDI: The Revolving Door and a Ray Of Hope.
Kathy Bischoff (Speaker) Coordinator, VHA Program, C Diff Foundation
Sponsored by
ACURX Pharmaceuticals
Clorox Healthcare
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
